Search

Search for
Advanced filters
Keyword(s)	Delete

Additional Search Options (click to show) Additional Search Options (click to hide)

Search categories
Authors
Title
Abstract
Full Text
Search in PDF
Supplementary File(s)
Publication Date
From
Until
Index terms
Discipline(s)
Type (method/approach)
Coverage
All index term fields

Issue

Title

Authors

Vol 10, No 6 (2010)

Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy

H. Schonthal A.

(Eng)

Vol 10, No 7 (2010)

STAT3 as a Therapeutic Target for Glioblastoma

Liu Y., Li C., Lin J.

(Eng)

Vol 14, No 2 (2014)

Artesunate Enhances the Antiproliferative Effect of Temozolomide on U87MG and A172 Glioblastoma Cell Lines

Karpel-Massler G., Westhoff M., Kast R., Dwucet A., Nonnenmacher L., Wirtz C., Debatin K., Halatsch M.

(Eng)

Vol 11, No 8 (2011)

Angiogenesis in Glioblastoma Multiforme: Navigating the Maze

G. Linkous A., M. Yazlovitskaya E.

(Eng)

Vol 10, No 6 (2010)

Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells

M. Hofman F., Stathopoulos A., A. Kruse C., C. Chen T., E.J.C. Schijns V.

(Eng)

Vol 23, No 11 (2023)

Glioblastoma as a Novel Drug Repositioning Target: Updated State

Hosseinalizadeh H., Ebrahimi A., Tavakoli A., Monavari S.

(Eng)

Vol 14, No 1 (2014)

The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide

Huang G., Ho B., Conroy J., Liu S., Qiang H., Golubovskaya V.

(Eng)

Vol 11, No 8 (2011)

Therapeutic Strategies to Target Multiple Kinases in Glioblastoma

Sathornsumetee S.

(Eng)

Vol 14, No 1 (2014)

The Microarray Gene Profiling Analysis of Glioblastoma Cancer Cells Reveals Genes Affected by FAK Inhibitor Y15 and Combination of Y15 and Temozolomide

Huang G., Ho B., Conroy J., Liu S., Qiang H., Golubovskaya V.

(Eng)

Vol 16, No 11 (2016)

Lenalidomide in an in vitro Dendritic Cell Model for Malignant Gliomas

Kühnöl C., Staege M., Kramm C.

(Eng)

Vol 13, No 3 (2013)

Heterocyclic Chalcone Analogues as Potential Anticancer Agents

Sharma V., Kumar V., Kumar P.

(Eng)

Vol 11, No 4 (2011)

Anti-Cancer Activity of Nitrones and Observations on Mechanism of Action

A. Floyd R., K. Chandru H., He T., Towner R.

(Eng)

Vol 10, No 6 (2010)

Therapeutic Exploitation of Apoptosis and Autophagy for Glioblastoma

Kogel D., Fulda S., Mittelbronn M.

(Eng)

Vol 24, No 5 (2024)

Dexamethasone Suppresses IL-33-exacerbated Malignant Phenotype of U87MG Glioblastoma Cells via NF-κB and MAPK Signaling Pathways

Ai J., Weng Y., Jiang L., Liu C., Liu H., Chen H.

(Eng)

Vol 16, No 1 (2016)

CXCR4 and Glioblastoma

Richardson P.

(Eng)

Vol 12, No 8 (2012)

Gambogic Acid is a Novel Anti-cancer Agent that Inhibits Cell Proliferation, Angiogenesis and Metastasis

Wang X., Chen W.

(Eng)

Vol 10, No 9 (2010)

Topoisomerase I Inhibitors in the Treatment of Primary CNS Malignancies: An Update on Recent Trends

P. Sasine J., Savaraj N., G. Feun L.

(Eng)

Vol 10, No 10 (2010)

Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation

Mas-Moruno C., Rechenmacher F., Kessler H.

(Eng)

Vol 24, No 10 (2024)

Investigating the Effects of Dorema hyrcanum Root Extracts on Selective Induction of Programmed Cell Death in Glioblastoma, Ovarian Cancer and Breast Cancer Cell Lines

Shandi M., Sahranavard S., Bagheri F., Shahsavari Z., Salami S.

(Eng)

Vol 14, No 8 (2014)

Tapasin and Human Leukocyte Antigen Class I Dysregulation Correlates with Survival in Glioblastoma Multiforme

Thuring C., Geironson L., Paulsson K.

(Eng)

Vol 11, No 8 (2011)

The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment

E. Kast R., Scheuerle A., R. Wirtz C., Karpel-Massler G., Halatsch M.

(Eng)

Vol 10, No 7 (2010)

Emerging Therapeutic Targets and Agents for Glioblastoma Migrating Cells

Di C., K. Mattox A., Harward S., Adamson C.

(Eng)

Vol 10, No 1 (2010)

An Orally Bioavailable c-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth

Guessous F., Zhang Y., diPierro C., Marcinkiewicz L., Sarkaria J., Schiff D., Buchanan S., Abounader R.

(Eng)

Vol 24, No 1 (2024)

Anticancer Potential of Novel Cinnamoyl Derivatives against U87MG and SHSY-5Y Cell Lines

Gouleni N., Di Rienzo A., Oner S., Karagöz C., Arslan M.E., Mardinoglu A., Turkez H., Di Stefano A., Vassiliou S., Cacciatore I.

(Eng)

Vol 14, No 8 (2014)

Microenvironment and Brain Tumor Stem Cell Maintenance: Impact of the Niche

Herold-Mende C., Mock A.

(Eng)

Vol 11, No 8 (2011)

Erlotinib in Glioblastoma - Lost in Translation?

Karpel-Massler G., Andrew Westhoff M., E. Kast R., Rainer Wirtz C., Halatsch M.

(Eng)

Vol 10, No 7 (2010)

Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors

J. Chalmers A.

(Eng)

Vol 25, No 19 (2025)

Recent Approaches on Oncolytic Viruses, Aptamers, TTFields and Personalized Treatment used for the Management of Glioblastoma: A Comprehensive Review

Singh A., Kanda A., Kanda J.

(Eng)

Vol 14, No 4 (2014)

Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment

Veenman L., Gavish M., Kugler W.

(Eng)

Vol 11, No 8 (2011)

Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma

G. Rainov N., Heidecke V.

(Eng)

Vol 23, No 19 (2023)

Impact of Ferroptosis Inducers on Chronic Radiation-exposed Survivor Glioblastoma Cells

Erdem İ.

(Eng)

Vol 14, No 3 (2014)

Synthesis and In Vitro Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives as Potent Antiglioma Agents

Patil R., Hosni-Ahmed A., Jones T., Patil S., Asres L., Wang X., Yates R., Geisert E., Miller D.

(Eng)

Vol 11, No 8 (2011)

Targeting βIII-Tubulin in Glioblastoma Multiforme: From Cell Biology and Histopathology to Cancer Therapeutics

D. Katsetos C., Draber P., Kavallaris M.

(Eng)

Vol 10, No 6 (2010)

Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets

Kondo T.

(Eng)

Vol 23, No 13 (2023)

Targeting the LINC00324/miR-16-5p/SEPT2 Signaling Cascade is Effective to Reverse Malignant Phenotypes in Glioblastoma

Chen B., Lin P., Li N.

(Eng)

1 - 35 of 35 Items

Search tips:

Search terms are case-insensitive
Common words are ignored
By default only articles containing all terms in the query are returned (i.e., AND is implied)
Combine multiple words with OR to find articles containing either term; e.g., education OR research
Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Username
Password
Remember me

Forgot password?	Register

Username
Password
Remember me

Forgot password?	Register

Search

Advanced filters

Search categories

Publication Date

Index terms

Search tips: